GenomesDAO GENOME
GENOME
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
GenomesDAO (GENOME) is a UK-registered DeSci project co-founded by Dr. Mark Hahnel and Aldo de Pape focused on genomic data security and monetization using AMD SEV technology. Despite a clear real-world value proposition, the project exhibits significant weaknesses across almost all operational dimensions. Active development has largely stalled following a token consolidation in May 2024, with no significant shipping activity recorded in 2025 or 2026. On-chain traction and community engagement are virtually non-existent, reflecting zero transaction activity on Etherscan and an illiquid micro-cap valuation under $400K. The tokenomics suffer from severe lack of transparency regarding historical allocations, accompanied by an approximate 99% drawdown from all-time highs. From a security and governance standpoint, no third-party smart contract audits exist for its token contracts, operational DAO mechanisms remain unverified, and the genomic data sector carries overarching national-security regulatory sensitivity. With no catastrophic security exploits or fraud identified, the low rating reflects project stasis, lack of audit validation, and negligible market traction.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About GenomesDAO GENOME (GENOME)
GenomesDAO (GENOME) is the utility and governance token of Genomes.io, a UK-registered decentralized science (DeSci) platform focused on genomic data security and monetization. Founded in 2018 by Dr. Mark Hahnel and Aldo de Pape, the project operates on Ethereum and Base and utilizes AMD Secure Encrypted Virtualisation (SEV) technology for encrypted data storage. The GENOME token was established through a token consolidation in early 2024 to replace predecessor tokens, functioning as a payment medium for genomic data queries, Snapshot governance, and liquidity incentives.
The token features a fixed supply of 1 billion units with no ongoing emission schedule. However, public documentation lacks transparency regarding historical token allocations and vesting schedules. Although Snapshot governance is designated as a primary utility, verified on-chain governance activity is undocumented, leaving organizational control centralized with the co-founders. Development on the project has stalled following the 2024 consolidation, with no notable GitHub releases or roadmap updates recorded in 2025 or 2026.
GENOME has experienced a severe market contraction, falling approximately 99% from its all-time high with near-zero trading liquidity and negligible on-chain transaction activity. The token smart contracts lack verified third-party security audits or independent team identity verification. While GenomesDAO has no recorded history of smart contract exploits, hacks, or regulatory enforcement actions, handling genomic assets places the project within a sector characterized by emerging national-security and data-custody regulatory scrutiny.